Net profit of Bafna Pharmaceuticals rose 5.65% to Rs 2.62 crore in the quarter ended September 2024 as against Rs 2.48 crore during the previous quarter ended September 2023. Sales declined 0.88% to Rs 40.32 crore in the quarter ended September 2024 as against Rs 40.68 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 40.32 | 40.68 | -1 |
| OPM % | 9.42 | 9.83 | - |
| PBDT | 4.20 | 3.72 | 13 |
| PBT | 2.62 | 2.48 | 6 |
| NP | 2.62 | 2.48 | 6 |